Bavarian Nordic AS (CHIX:BAVAC) FCF Margin %: -76.60% (As of Mar. 2026)

What is Bavarian Nordic AS FCF Margin %?

Bavarian Nordic AS CHIX:BAVAC 84 FCF Margin % is -76.60% as of Mar. 2026. GuruFocus rates CHIX:BAVAC with a GF Score™ of 84/100 and a GF Value™ of kr175.27 (Fairly Valued). The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Bavarian Nordic AS ranks better than 90.21% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bavarian Nordic AS's Free Cash Flow for the three months ended in Mar. 2026 was kr-810 Mil. Bavarian Nordic AS's Revenue for the three months ended in Mar. 2026 was kr1,058 Mil. Therefore, Bavarian Nordic AS's FCF Margin % for the quarter that ended in Mar. 2026 was -76.60%.

As of today, Bavarian Nordic AS's current FCF Yield % is 9.64%.

The historical rank and industry rank for Bavarian Nordic AS's FCF Margin % or its related term are showing as below:

CHIX:BAVAc' s FCF Margin % Range Over the Past 10 Years
Min: -444.83 Med: -2.64 Max: 21.95
Current: 21.95

During the past 13 years, the highest FCF Margin % of Bavarian Nordic AS was 21.95%. The lowest was -444.83%. And the median was -2.64%.

CHIX:BAVAc's FCF Margin % is ranked better than
90.21% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs CHIX:BAVAc: 21.95

Bavarian Nordic AS FCF Margin % Related Terms

Bavarian Nordic AS FCF Margin % Historical Data

* Premium members only.

The historical data trend for Bavarian Nordic AS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS FCF Margin % Chart

Bavarian Nordic AS Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

-74.66

-36.86

2.01

4.59

21.82

Bavarian Nordic AS Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-56.05	28.28	69.46	27.82	-76.60

CHIX:BAVAC vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Bavarian Nordic AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bavarian Nordic AS FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's FCF Margin % falls into.

Save Embed

84GF Score

Bavarian Nordic AS CHIX:BAVAC

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bavarian Nordic AS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bavarian Nordic AS's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	1362.608	/	6243.956
	=	21.82 %

Bavarian Nordic AS's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-810.261	/	1057.845
	=	-76.60 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -76.60% mean?

Bavarian Nordic AS (CHIX:BAVAC) has a FCF Margin % of -76.60% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bavarian Nordic AS and its competitors. According to the industry distribution chart, Bavarian Nordic AS ranks #94 out of 960 companies in the Biotechnology industry, placing it in the top 9.8%.

Is Bavarian Nordic AS's FCF Margin % too high?

Bavarian Nordic AS's current FCF Margin % is -76.60%. Based on the distribution chart, Bavarian Nordic AS ranks #94 out of 960 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bavarian Nordic AS has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Bavarian Nordic AS's FCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Bavarian Nordic AS ranks #94 out of 960 companies for FCF Margin %. This places Bavarian Nordic AS in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bavarian Nordic AS and its competitors. Bavarian Nordic AS's current FCF Margin % is -76.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bavarian Nordic AS stock overvalued right now?

Based on GuruFocus' analysis, Bavarian Nordic AS (CHIX:BAVAC) is currently considered Fairly Valued. The stock's GF Value™ is kr175.27, compared to a current price of kr188.30 — trading 7.4% above its estimated fair value. The current FCF Margin % is -76.60%. Bavarian Nordic AS's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current FCF Margin % is -76.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of kr188.30 is trading 7.4% above its estimated GF Value™ of kr175.27. GuruFocus considers Bavarian Nordic AS to be Fairly Valued.

Key valuation signals for CHIX:BAVAC:

FCF Margin %: -76.60%
GF Value™: kr175.27 vs. price of kr188.30 (7.4% above fair value)
GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bavarian Nordic AS Business Description

Industry Healthcare Biotechnology

Comparable Companies OCSE:ZEAL OCSE:GUBRA OCSE:PEG OCSE:STRAP OCSE:ALK B VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270 RPRX BNTX INSM ROIV INCY

Other Exchanges BVNRY:USA BVNKF:USA 0DPB:UK BAVA:Denmark BV3:Germany BAVA:Austria

Address Philip Heymans Alle 3, Hellerup, DNK, 2900

Website https://www.bavarian-nordic.com

Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.

84GF Score

Get the complete analysis for CHIX:BAVAC

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr188.30

Price

kr175.27

GF Value

View CHIX:BAVAC Analysis

See FCF Margin % data for all stocks →